| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 29.29B | 27.72B | 23.65B | 19.52B | 15.13B | 16.63B |
| Gross Profit | 14.22B | 13.27B | 11.21B | 2.19B | 980.00M | 1.08B |
| EBITDA | 973.00M | 676.00M | 4.41B | 3.68B | 1.55B | 1.90B |
| Net Income | 4.32B | -667.00M | 3.44B | -2.46B | 43.00M | 352.00M |
Balance Sheet | ||||||
| Total Assets | 56.09B | 55.01B | 50.47B | 46.83B | 41.72B | 39.53B |
| Cash, Cash Equivalents and Short-Term Investments | 7.07B | 6.76B | 6.68B | 6.93B | 5.35B | 3.75B |
| Total Debt | 5.11B | 5.06B | 6.58B | 6.95B | 7.13B | 7.01B |
| Total Liabilities | 42.31B | 44.29B | 38.38B | 35.96B | 28.45B | 26.78B |
| Stockholders Equity | 13.22B | 10.18B | 11.58B | 10.41B | 12.84B | 12.35B |
Cash Flow | ||||||
| Free Cash Flow | 3.58B | 3.19B | 3.44B | 2.95B | 2.00B | 1.34B |
| Operating Cash Flow | 5.13B | 4.73B | 4.27B | 3.54B | 2.44B | 1.87B |
| Investing Cash Flow | -1.87B | -1.85B | -1.70B | -1.29B | -738.00M | -799.00M |
| Financing Cash Flow | -2.21B | -3.07B | -2.58B | -815.00M | -268.00M | 68.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | $92.32B | 22.15 | 17.78% | 1.73% | 11.86% | 17.39% | |
75 Outperform | $80.36B | 20.21 | 26.15% | 1.55% | -0.14% | 72.35% | |
75 Outperform | $235.48B | 36.06 | 10.49% | 1.47% | 8.79% | 39.63% | |
74 Outperform | $148.32B | 31.49 | 34.32% | 0.96% | 14.84% | 164.83% | |
70 Outperform | $108.74B | 26.50 | 62.78% | 2.81% | 2.88% | -35.15% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
47 Neutral | $145.79B | ― | ― | ― | 10.19% | -6.03% |